Aredia (Pamidronate disodium)

Class of Drugs: Biophosphonate

Manufacturer: Novartis Pharmaceuticals

Information on Patient Assistance program:
The Partnership for Prescription Assistance -1-888-4PPA-NOW (1-888-477-2669) or
Novartis Patient Assitance Plan

Description: Pamidronate disodium is a white powder that is administered intravenously. The solution should be clear with no particles floating in it..

Ingredient: Pamidronate disodium

Use: Aredia inhibits bone resorption in Paget's Disease and bone metastases associated with breast cancer.

Warnings:
Severe mineral unbalance can result from this treatment. Blood levels of calcium, phosphate, magnesium and potassium must be closely monitored while on Ariedia.

Aredia must not be mixed with calcium containing solutions (such as Ringer's) and should be given in a separate IV line.

Side Effects: Side effects include a slight fever following administration of the drug, generalized pain, hypertension, abdominal pain, anorexia, constipation, nausea, vomiting, urinary tract infections, bone pain, anemia, mineral and electrolyte imbalaces were reported due to low bood levels of the minerals cited above. Treatment with IV or oral mineral supplements  may be necessary if the blood levels drop too low.

Renal impairment was reported in a small percentage of patients in clinical trials. While on Aredia, care should be taken to drink adequate amounts of fluids. This reduces the risk of urinary tract and kidney complications.

There have been incidences of anaphylactic shock reported as a result of the administration of this medication.

References: Aredia (Pamidronate disodium)

Return to Drug Index

This information is intended as reference and not as medical advice. All treatment decisions should be made with your team of medical professionals and prescriptions must be given by your doctor. See TERMS AND CONDITIONS.